Experimental Pathology, Malmö
11 – 20 of 158
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Natural flavonoids exhibit potent anticancer activity by targeting microRNAs in cancer : A signature step hinting towards clinical perfection
(
- Contribution to journal › Article
- 2022
-
Mark
Computational Evidence Based Perspective on the Plausible Repositioning of Fluoroquinolones for COVID-19 Treatment
(
- Contribution to journal › Article
-
Mark
Increased MARCKS Activity in BRAF Inhibitor-Resistant Melanoma Cells Is Essential for Their Enhanced Metastatic Behavior Independent of Elevated WNT5A and IL-6 Signaling
(
- Contribution to journal › Article
- 2021
-
Mark
A review emphasizing on utility of heptad repeat sequence as a tool to design pharmacologically safe peptide-based antibiotics
(
- Contribution to journal › Scientific review
-
Mark
Targeting Oncogenic WNT Signalling with WNT Signalling-Derived Peptides
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Reduced WNT5A signaling in melanoma cells favors an amoeboid mode of invasion
(
- Contribution to journal › Article
-
Mark
Translational research in drug discovery : Tiny steps before the giant leap
2021) p.347-369(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2020
-
Mark
WNT5A-induced activation of the protein kinase C substrate MARCKS is required for melanoma cell invasion
(
- Contribution to journal › Article
- 2019
-
Mark
Combination therapy targeting the elevated interleukin-6 level reduces invasive migration of BRAF inhibitor-resistant melanoma cells
(
- Contribution to journal › Article
-
Mark
The WNT5A Agonist Foxy5 Reduces the Number of Colonic Cancer Stem Cells in a Xenograft Mouse Model of Human Colonic Cancer
(
- Contribution to journal › Article